These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27609614)

  • 1. Are recent statin recommendations to employ fixed doses and abandon targets effective for treatment of hypercholesterolaemia? Investigation based on number needed to treat.
    Soran H; Adam S; Durrington PN
    Eur J Prev Cardiol; 2017 Jan; 24(1):76-83. PubMed ID: 27609614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Data to Identify Hypercholesterolemia Patients on Suboptimal Statin Therapy.
    Kajinami K; Ozaki A; Tajima Y; Yamashita S; Arai H; Teramoto T
    J Atheroscler Thromb; 2019 May; 26(5):408-431. PubMed ID: 30369517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network.
    Egan BM; Sutherland SE; Childers WF; Dahlheimer RM; Helmrich GA; Lapeyrolerie DA; Markle N; Murphy DW; Simmons L; Davis RA; Tilkemeier P; Sinopoli A
    Ther Adv Cardiovasc Dis; 2016 Apr; 10(2):56-66. PubMed ID: 26733598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of lower risk thresholds for statin treatment in primary prevention: analysis of CPRD and simulation modelling of annual cholesterol monitoring.
    McFadden E; Stevens R; Glasziou P; Perera R
    Prev Med; 2015 Jan; 70():14-6. PubMed ID: 25445333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying Unmet Need in Statin-Treated Hyperlipidemia Patients and the Potential Benefit of Further LDL-C Reduction Through an EHR-Based Retrospective Cohort Study.
    Schleyer T; Hui S; Wang J; Zhang Z; Knapp K; Baker J; Chase M; Boggs R; Simpson RJ
    J Manag Care Spec Pharm; 2019 May; 25(5):544-554. PubMed ID: 31039062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy.
    Brinton EA
    Clin Cardiol; 2018 Jun; 41(6):710-720. PubMed ID: 29749101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.
    McElduff P; Jaefarnezhad M; Durrington PN
    Heart; 2006 Sep; 92(9):1213-8. PubMed ID: 16717068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter?
    Nixon JV
    Vasc Health Risk Manag; 2006; 2(4):441-6. PubMed ID: 17323598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SIC Position paper: Treat to prevent the first event - intensive LDL cholesterol lowering in patients at very high cardiovascular risk without a previous cardiovascular event. From ESC guidelines to clinical practice].
    Perrone Filardi P; Nardi E; Agostoni P; Barillà F; Calabrò P; Ciccone MM; Curcio A; Indolfi C; Muscoli S; Nodari S; Paolillo S; Patti G; Porto I; Sinagra G; Gallo L; Fontanarosa S; Vizza CD; Gargiulo P
    G Ital Cardiol (Rome); 2024 Jul; 25(7):530-540. PubMed ID: 38916469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of the cost-effectiveness of statins.
    Morrison A; Glassberg H
    J Manag Care Pharm; 2003; 9(6):544-51. PubMed ID: 14664662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update for primary healthcare providers: recent statin trials and revised National Cholesterol Education Program III guidelines.
    Hennekens CH; Hollar D; Eidelman RS; Agatston AS
    MedGenMed; 2006 Feb; 8(1):54. PubMed ID: 16915184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of predictors upon the reduction of lipid parameters in family medicine practice.
    Doganer YC; Angstman K; Rohrer J; Merry S
    Sao Paulo Med J; 2015; 133(5):428-34. PubMed ID: 26648432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red Yeast Rice for Hypercholesterolemia.
    Cicero AFG; Fogacci F; Banach M
    Methodist Debakey Cardiovasc J; 2019; 15(3):192-199. PubMed ID: 31687098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations.
    Shepardson NE; Shankar GM; Selkoe DJ
    Arch Neurol; 2011 Nov; 68(11):1385-92. PubMed ID: 22084122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jeremiah Metzger Lecture: cholesterol, inflammation and atherosclerotic cardiovascular disease: is it all LDL?
    Gotto AM
    Trans Am Clin Climatol Assoc; 2011; 122():256-89. PubMed ID: 21686232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events.
    Brown RE; Welsh P; Logue J
    Open Heart; 2020 Dec; 7(2):. PubMed ID: 33443127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet.
    Diamond DM; Bikman BT; Mason P
    Curr Opin Endocrinol Diabetes Obes; 2022 Oct; 29(5):497-511. PubMed ID: 35938780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Impact & Efficiency of Benefit-Targeted Versus Risk-Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease.
    Pletcher MJ; Pignone M; Jarmul JA; Moran AE; Vittinghoff E; Newman T
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28188251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to non-HDL cholesterol goal attainment by providers.
    Virani SS; Steinberg L; Murray T; Negi S; Nambi V; Woodard LD; Bozkurt B; Petersen LA; Ballantyne CM
    Am J Med; 2011 Sep; 124(9):876-80.e2. PubMed ID: 21854896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Practical Statin Recommendation System Based on Real-World Data to Improve LDL-C Management in Secondary Prevention.
    Zhang Y; Zhang D; Liu X; Peng W; Mu Y; Li Y; Qiu Q
    J Cardiovasc Pharmacol; 2023 May; 81(5):373-380. PubMed ID: 36791397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.